Literature DB >> 15650269

Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.

Daniela Foderà1, Natale D'Alessandro, Antonella Cusimano, Paola Poma, Monica Notarbartolo, Nadia Lampiasi, Giuseppe Montalto, Melchiorre Cervello.   

Abstract

The aim of the present study was to examine the effects of nonselective (indomethacin) and selective cyclooxygenase-2 (COX-2) inhibitors (NS-398, nimesulide, and CAY10404) on cell growth, cell cycle distribution, and apoptosis in three human hepatocellular carcinoma cell lines (HepG2, HuH-6, and HA22T/VGH) with different characteristics of differentiation and biological behavior. The four COX inhibitors showed a dose-dependent growth-inhibitory effect in all the cell lines. No substantial arrests in the progression of the cells through the cell cycle were observed after treatment of HuH-6 or HA22T/VGH for 48 h with the various inhibitors. On the other hand, there were significant increases in apoptosis, with the highest effect of cell kill being seen after treatment with indomethacin, especially in HuH-6. Our findings support the suggestion that selective or, perhaps more efficiently, nonselective COX-2 inhibitors may have potential therapeutic effects in hepatocellular carcinoma. Further studies must be carried out to better determine the possible mechanisms of these effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15650269     DOI: 10.1196/annals.1322.052

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  19 in total

1.  Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.

Authors:  Tracey G Simon; Ann-Sofi Duberg; Soo Aleman; Raymond T Chung; Andrew T Chan; Jonas F Ludvigsson
Journal:  N Engl J Med       Date:  2020-03-12       Impact factor: 91.245

Review 2.  Cyclooxygenases in hepatocellular carcinoma.

Authors:  Melchiorre Cervello; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

3.  NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.

Authors:  Jessica L Petrick; Vikrant V Sahasrabuddhe; Andrew T Chan; Michael C Alavanja; Laura E Beane-Freeman; Julie E Buring; Jie Chen; Dawn Q Chong; Neal D Freedman; Charles S Fuchs; John Michael Gaziano; Edward Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lifang Hou; Eric J Jacobs; Lindsay Y King; Jill Koshiol; I-Min Lee; Martha S Linet; Julie R Palmer; Mark P Purdue; Lynn Rosenberg; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Peter T Campbell; Katherine A McGlynn
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-21

Review 4.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Authors:  Katherine A McGlynn; Jessica L Petrick; W Thomas London
Journal:  Clin Liver Dis       Date:  2015-02-26       Impact factor: 6.126

5.  Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Yanan Ma; Jonas F Ludvigsson; Dawn Q Chong; Edward L Giovannucci; Charles S Fuchs; Jeffrey A Meyerhardt; Kathleen E Corey; Raymond T Chung; Xuehong Zhang; Andrew T Chan
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

6.  Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.

Authors:  Ji Yeon Baek; Wonhee Hur; Jin Sang Wang; Si Hyun Bae; Seung Kew Yoon
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

7.  Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink.

Authors:  Baiyu Yang; Jessica L Petrick; Jie Chen; Katrina Wilcox Hagberg; Vikrant V Sahasrabuddhe; Barry I Graubard; Susan Jick; Katherine A McGlynn
Journal:  Cancer Epidemiol       Date:  2016-07-13       Impact factor: 2.984

Review 8.  Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Andrew T Chan
Journal:  Clin Liver Dis       Date:  2020-08-25       Impact factor: 6.126

9.  Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

Authors:  Vikrant V Sahasrabuddhe; Munira Z Gunja; Barry I Graubard; Britton Trabert; Lauren M Schwartz; Yikyung Park; Albert R Hollenbeck; Neal D Freedman; Katherine A McGlynn
Journal:  J Natl Cancer Inst       Date:  2012-11-28       Impact factor: 13.506

Review 10.  Aspirin in Hepatocellular Carcinoma.

Authors:  Emanuela Ricciotti; Kirk J Wangensteen; Garret A FitzGerald
Journal:  Cancer Res       Date:  2021-04-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.